New York, May 25, 2021 (GLOBE NEWSWIRE) – Reportlinker.com Announces the Release of the “South and Central America Irritable Bowel Syndrome Diagnostics Market Forecast to 2028 – Impact of COVID-19 and Regional Analysis by diagnosis and indication “- https://www.reportlinker.com/p06075782/?utm_source=GNW
2% from 2021 to 2028. Market growth is determined owing to some of the major driving factors such as the increasing prevalence of Irritable Bowel Syndrome and associated conditions and advancements in the diagnosis of the syndrome. On the other hand, the challenges in diagnosing IBS are likely to restrain the growth of the market during the forecast years.
Irritable Bowel Syndrome is a chronic gastrointestinal condition caused by disturbed bowel habits and abdominal pain. All over the world, people are witnessing a huge incidence of irritable bowel syndrome.
Some factors such as food allergies, developmental stages of gastroenteritis, sporadic movements of the colon, abnormal composition of serotonin in the colon, and mild celiac disease are some of the risk factors that cause colon syndrome. irritable. According to statistics from IBS Global Impact Report, in 2016, Latin America had an estimated prevalence rate of IBS of 17.5%. Such a staggering prevalence of Irritable Bowel Syndrome is likely to drive the Irritable Bowel Syndrome (IBS) diagnostics market over the forecast period. To combat irritable bowel syndrome, companies involved in the development of irritable bowel syndrome drugs are taking constructive steps to create awareness programs with the aim of raising awareness. Such initiatives are expected to drive the growth of the Irritable Bowel Syndrome (IBS) diagnostics market. In addition, the increasing number of FDA approvals and diagnostic development activities is likely to accelerate the growth of Irritable Bowel Syndrome (IBS) diagnostics market during the forecast period.
With the spread of the COVID-19 pandemic, it is discovered that a significant number of people across the world are suffering from Irritable Bowel Syndrome (IBS), as the COVID-19 pandemic has affected the psychological health of people, causing a higher level of stress can exaggerate the symptoms of irritable bowel syndrome (IBS).
Thus, the impact of COVID-19 is so far considered positive on the market. Hence, the increasing demand for Irritable Bowel Syndrome (IBS) diagnostics in South America and Central America is likely to drive the growth of Irritable Bowel Syndrome (IBS) diagnostics market.
On the basis of the diagnosis, the South and Central America Irritable Bowel Syndrome (IBS) Diagnosis market has been segmented into Laboratory Tests and Imaging Tests. In 2020, the laboratory testing segment held a larger share of the market and is expected to grow at a faster rate over the next few years.
On the basis of indication, South and Central America Irritable Bowel Syndrome (IBS) Diagnostics market is segmented into Pain & Cramps, Diarrhea, Constipation & Constipation & Alternating Diarrhea. Pain and Cramps segment held the largest market share in 2020 and is expected to register the highest market CAGR during the forecast period.
Some of the primary and secondary sources associated with this South and Central America Irritable Bowel Syndrome (IBS) Diagnostics market report are American Society for Gastrointestinal Endoscopy (ASGE), Centers for Disease Control and Prevention (CDC) and the International Foundation for Gastrointestinal Disorders (IFFGD).
Read the full report: https://www.reportlinker.com/p06075782/?utm_source=GNW
ReportLinker is an award winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.